Finance / AMLN (Amylin Pharmaceuticals, Inc.)

  Recs: 1 To me this story was a plant AP Amylin shares rise on Byetta prescriptions boost The story below, is a joke, it is so obviously a plant ...  We've had plenty of weeks were scripts results were better then this yet no story.  It might be a postive sign... It might mean that someone with influence has been accumulated AMLN and wants to see the ...

  Recs: 9 AP Amylin shares rise on prescription boost   AP Amylin shares rise on Byetta prescriptions boost Monday November 17, 12:36 pm ET Amylin Pharmaceuticals shares gain ground as Byetta prescriptions rise in early November NEW YORK (AP) -- Shares of biotechnology company Amylin ...

  Recs: 2 Sellers with report dates Scroll right. See you at $150, the best is yet to come. Tundra has it right. MLN: Amylin Pharmaceuticals Inc  Owners Details Click on column headings to sort! Fund Fund Type Fund Perf. Report Date Current Shares Current Value Value Chng. Return Activity Shares Chng.  ▾ ...

  Recs: 0 Business Week: "Amylin says it will cut 340 jobs to slash expenses" Amylin says it will cut 340 jobs to slash expenses // SAN DIEGO Drugmaker Amylin Pharmaceuticals Inc. said Monday it will eliminate 340 jobs, or a quarter of its San Diego work force, in a move it said will cut its operating expenses by more than 0 million in 2009....

  Recs: 0 WoW a fairly accurate AP News Release ! AP Amylin says it will cut 340 jobs to slash expenses Monday November 10, 8:12 pm ET Amylin to cut quarter of San Diego jobs to pare 2009 operating costs by $100 million SAN DIEGO (AP) -- Drugmaker Amylin Pharmaceuticals Inc. said Monday it will ...

  Recs: 0 Today's Google News Alerts for: Amylin Google News Alerts for: Amylin Amylin shares plunge on FDA study data rejection Forbes - NY,USA AP 11.04.08, 7:42 PM ET Shares of biotechnology company Amylin Pharmaceuticals Inc. plunged to a new low point Tuesday, after the company said its ......

Started a small position in Amylin Pharmaceuticals Inc. (AMLN)a biopharmaceutical company that is in the discovery, development, and commercialization of medicines for diabetes and obesity. The stock is selling at a seven year low due to a setback in one of their phase III trials for their diabetes drug exenatide LAR. Exenatide LAR, which would be taken once-weekly, is poised to be the ...

  Recs: 0 Zacks decides to take the high road and not jump on Amylin....NOT!> > > looks like a new writer too, not the usual Jason, who is probably still tooting his horn somewhere, "I was right, I was right" and "I helped to drive down the stock price!" :( Zacks.com FDA Frowns, Amylin Tanks Tuesday November 4, 4:49 pm ET By Aditi Samajpati...

* Eastbourne Capital says may seek sale of Amylin * Amylin shares rise 3.5 percent in extended trading (Adds filing details, background, stock price) LOS ANGELES, Nov 3 (Reuters) - Eastbourne Capital, which owned a 12.5-percent stake in Amylin Pharmaceuticals Inc (AMLN.O: Quote, Profile, Research, Stock Buzz) as of late August, said on Monday it intends to hold discussions on ways to ...

  Recs: 1 UPDATE 2-Amylin sinks after U.S. FDA rejects data     UPDATE 2-Amylin sinks after U.S. FDA rejects data Tue Nov 4, 2008 12:17pm EST (Recasts, adds analyst comments, updates share movement) By Susan Heavey WASHINGTON, Nov 4 (Reuters) - Shares of Amylin Pharmaceuticals Inc (AMLN.O: Quote , Profile , Research , Stock Buzz ) ...